Blood Cancer Clinical Trials 2022

Browse 30 Blood Cancer Medical Studies Across 69 Cities

1 Phase 3 Trial · 135 Blood Cancer Clinics

Reviewed by Michael Gill, B. Sc.
25 Blood Cancer Clinical Trials Near Me
Los Angeles, CA
New York, NY
Rochester, MN
San Francisco, CA
More Trial Locations
An interactive map to display trial locations for Cedars-Sinai Medical Center, Memorial Sloan Kettering Cancer Center, Mayo Clinic, University of California San Francisco, Medical Center at Paranassus, and 98 more locations.
Most Popular References for Blood Cancer Clinical Trials
Frequency
Citation
Top Hospitals for Blood Cancer Clinical Trials
Location
Active Blood Cancer Clinical Trials
All Time Trials for Blood Cancer
First Recorded Blood Cancer Trial
Trials
National Institutes of Health Clinical Center, Bethesda, Maryland
2
11
2003
Princess Margaret Cancer Centre, Toronto, Ontario
2
7
2014
Top Treatments for Blood Cancer Clinical Trials
Treatment Name
Active Blood Cancer Clinical Trials
All Time Trials for Blood Cancer
First Recorded Blood Cancer Trial
Trials
Omission of the drug mycophenolate mofetil
1
1
2022
COVID-19 Vaccine
1
1
2021
Top Cities for Blood Cancer Clinical Trials
City
Active Blood Cancer Clinical Trials
Top Active Site for Blood Cancer Clinical Trials
Trial List
New York, New York
7
Memorial Sloan Kettering Cancer Center
Houston, Texas
7
MD Anderson Cancer Center
Boston, Massachusetts
6
Massachusetts General Hospital
Most Recent Blood Cancer Clinical Trials
Phase 3 Blood Cancer Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Pediatric Blood Cancer Clinical Trials
Senior Friendly Blood Cancer Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Blood Cancer
Treatment
Year
Mechanism of Action
Sponsor
Active Blood Cancer Clinical Trials
Unmanipulated Umbilical Cord Blood (UCB)
2018
Angiocrine Bioscience
0
ABBV-621
2017
AbbVie
0
XmAb14045
2016
Xencor, Inc.
0
BMS-936558
2014
Nivolumab
Bristol-Myers Squibb
0

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 28th, 2021

Last Reviewed: September 3rd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.